Atossa Genetics Valuation
| ATOS Stock | USD 1.28 0.01 0.78% |
Today, the firm appears to be undervalued. Atossa Genetics shows a prevailing Real Value of $2.15 per share. The current price of the firm is $1.28. Our model approximates the value of Atossa Genetics from analyzing the firm fundamentals such as Current Valuation of 86.26 M, shares owned by insiders of 0.05 %, and Return On Equity of -0.31 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Atossa Genetics' valuation include:
Price Book 2.1854 | Enterprise Value 86.3 M | Enterprise Value Ebitda 2.0051 |
Undervalued
Today
Please note that Atossa Genetics' price fluctuation is very risky at this time. Calculation of the real value of Atossa Genetics is based on 3 months time horizon. Increasing Atossa Genetics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Atossa stock is determined by what a typical buyer is willing to pay for full or partial control of Atossa Genetics. Since Atossa Genetics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Atossa Stock. However, Atossa Genetics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.28 | Real 2.15 | Target 4.83 | Hype 1.28 | Naive 1.26 |
The intrinsic value of Atossa Genetics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Atossa Genetics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Atossa Genetics helps investors to forecast how Atossa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Atossa Genetics more accurately as focusing exclusively on Atossa Genetics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Atossa Genetics' intrinsic value based on its ongoing forecasts of Atossa Genetics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Atossa Genetics' closest peers.
Atossa Genetics Cash |
|
Atossa Valuation Trend
Atossa Genetics' real value is important for investors to make better decisions and a more accurate overall view of Atossa Genetics' financial worth over time. Using both Atossa Genetics' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Atossa Genetics Total Value Analysis
Atossa Genetics is presently estimated to have valuation of 86.26 M with market capitalization of 162.28 M, debt of 5.24 M, and cash on hands of 125.54 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Atossa Genetics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
86.26 M | 162.28 M | 5.24 M | 125.54 M |
Atossa Genetics Asset Utilization
One of the ways to look at asset utilization of Atossa is to check how much profit was generated for every dollar of assets it reports. Atossa Genetics shows a negative utilization of assets of -0.2 percent, losing $0.002035 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Atossa Genetics shows how discouraging it operates for each dollar spent on its assets.Atossa Genetics Ownership Allocation
Atossa Genetics holds a total of 125.8 Million outstanding shares. Almost 71.75 percent of Atossa Genetics outstanding shares are held by general public with 0.05 (percent) owned by insiders and only 28.21 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Atossa Genetics Profitability Analysis
Net Loss for the year was (30.09 M) with profit before overhead, payroll, taxes, and interest of 0.About Atossa Genetics Valuation
The stock valuation mechanism determines Atossa Genetics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Atossa Genetics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Atossa Genetics. We calculate exposure to Atossa Genetics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Atossa Genetics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -23 K | -21.9 K | |
| Pretax Profit Margin | -8.3 K | -7.9 K | |
| Operating Profit Margin | -8.3 K | -7.9 K | |
| Net Loss | -10.3 K | -9.8 K | |
| Gross Profit Margin | (85.47) | (81.19) |
Atossa Genetics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Atossa Genetics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 126.1 M | |
| Shares Float | 118 M |
Atossa Genetics Current Valuation Indicators
Atossa Genetics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Atossa Genetics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Atossa Genetics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Atossa Genetics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Atossa Genetics' worth.Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.